Patent Grant
11207028
This invention relates to the field of monitoring medical and health data (e.g., vital signs, electrocardiogram, blood pressure, pulse oximetry, electroencephalogram) in the setting of magnetic resonance imaging (MRI) and MRI-guided procedures, X-ray and X-ray-guided procedures, and other sources of electromagnetic interference.
The following acronyms are used in this specification:
Physiological monitoring has become an essential part of health and disease management. A number of monitoring modalities, sensors, and systems have been developed for various settings and patient groups. They include in-hospital monitoring systems (e.g., bedside monitors and systems for patient monitoring during surgeries and other medical procedures) as well as out-of-hospital (ambulatory) and home monitoring systems. The most common types of collected information are electrocardiogram (ECG), electroencephalogram (EEG), electromyogram (EMG), temperature, respiration (breathing) rate and amplitude, oxygen saturation (pulse oximetry), arterial blood pressure (ABP), glucose, hemoglobin, physical activity, vascular resistance, and cardiac output.
The majority of in-hospital monitoring systems collect data from multiple sensors and/or channels. For example, cardiovascular hemodynamic monitoring often includes 12-lead ECG and 4 blood-pressure and pulse-oximetry channels; cardiac electrophysiological monitoring systems include at least 8 surface ECG channels and additional channels for collecting intracardiac electrograms, whereas EEG monitoring systems may incorporate up to 100 channels.
Systems for external cardiac defibrillation and pacing also require cardiovascular monitoring (e.g., ECG, blood pressure, pulse oximetry) in order to evaluate cardiac rhythm before and after defibrillation (electrical discharge or shock) or cardiac pacing, to detect cardiac arrhythmias (e.g., ventricular fibrillation, ventricular tachycardia, atrial fibrillation), or to perform a cardioversion (i.e., a synchronized shock delivered at a specific time point of the cardiac cycle, usually within the QRS complex on the ECG, which coincides with ventricular depolarization) or demand pacing, in which the patient's cardiac beats are monitored and pacing is inhibited when they are detected.
Because most physiological signals are relatively small and require frequent data sampling and real-time data transmission, both EMI and wireless data transmission represent major challenges for the development of such monitoring systems, as detailed below.
I. Electromagnetic Interference
Powerful sources of electromagnetic interference (EMI) that are usually present in a modern hospital environment can generate substantial amount of noise, distortion, and interference. The magnetic resonance imaging (MRI) scanner is an example of a powerful source of EMI, which can lead to signal artifacts that are several orders of magnitude greater than ECG or EEG signals. This interference becomes particularly important due to the requirement for high-fidelity, diagnostic ECG-monitoring during interventional cardiovascular MR (CMR) procedures and tracking subtle changes in the amplitude of the ECG ST segment and T wave, which may signal the earliest signs of ischemia in patients with coronary artery disease. Moreover, interventional CMR procedures also require rapid patient transportation (with continuous monitoring) between the MRI scanner room and X-ray room. Due to the requirement of continuous monitoring during both procedures, as well during transportation between the two rooms, a single wireless system must be used for this setting. The frequency of the signals generated by the MRI scanner's gradient magnetic fields (GMF interference) often overlaps with the frequency of cardiac signals (true ECG). In this situation, ECG signals represent a combination of the true ECG and GMF interference. Because the amplitude of MR gradients (GMF) is usually several orders of magnitude greater than the amplitude of the true ECG, MR-contaminated signals require substantial filtering, which modifies the pattern of the cardiac signals and diminishes its diagnostic value. In addition, the patterns of ECG signals in the presence of strong magnetic fields are changed by the magneto-hydrodynamic effect (MHE), which arises due to the circulation of magnetized blood in an individual's body. Although a number of filtering and reconstruction approaches have been developed to address this issue, an accurate, high-fidelity reconstruction of the diagnostic quality true-ECG signal remains a challenge (Wu et al. Adaptive noise cancellation to suppress electrocardiography artifacts during real-time interventional MRI. J Magnetic Resonance Imaging 33[5]:1184-93 [2011]).
The prior-art approaches to the EMI filtering of physiological signals can be divided into three groups:
To summarize, the prior art approaches did not provide the detection of strong EMI (in particular GMF) in physiological signals using the properties of GMF waveforms and the differences between the GMF waveforms and physiological data. Therefore, to detect GMF, the prior-art methods and systems require a special source of GMF information (e.g., a cable connected to the MRI scanner or coil/antenna for the GMF detection).
II. Wireless Communication
Wireless connectivity offers mobility and convenience, which cannot be achieved using wire-based systems. In a hospital setting, this allows uninterrupted patient monitoring and movement of patients between different procedure/surgery rooms, intensive care units, emergency rooms, and hospital beds. In an out-of-hospital or home setting, wireless systems allow continuous monitoring during sleep and daily activities; they can also be used on the road and in other settings.
However, wireless data transmission poses several challenges compared with wire-based systems. First, the speed and rate of wireless data transmission are limited. This creates significant problems for the development of multi-channel/multi-sensor wireless systems (such as cardiac electrophysiological systems, cardiac hemodynamic monitoring, or EEG-mapping systems), which require significant data throughput. Furthermore, wireless systems are susceptible to electromagnetic noise and interference from external sources. This issue is particularly important for medical monitoring in the emergency setting and during interventional procedures, where uninterrupted, high-fidelity, real-time data are essential for patient diagnosis and management. The rapid proliferation of medical equipment with powerful electromagnetic sources (e.g., MRI scanners and X-ray machines) makes this issue particularly challenging in the modern hospital environment. Changing patient monitoring systems when a patient is moved for different diagnostic procedures and treatment throughout a hospital requires detachment and reattachment of multiple ECG leads and other sensors, adding a burden of time, effort, and cost for medical institutions and creating discontinuities (gaps) in patient monitoring.
Traditionally, wireless radiofrequency (RF) transmitters have been viewed as a simple replacement for wire-based data transmission. Thus, wireless system designs have essentially copied wire-based systems and added a single RF transmitter/receiver (Bluetooth, WiFi, Zigbee, cell phone, etc.). However, as explained above, this design strategy can lead to several problems. Specifically, a single RE transmitter has a limited data throughput, which may not be sufficient for multi-channel, high-sampling-rate data monitoring. Furthermore, wireless communication, using a single transmitter, can be significantly affected or completely interrupted by external EMI, potentially complicating patient management and outcomes in emergency settings, where transmission errors, delays, or interruptions may lead to delayed or inappropriate medical response and may be life threatening. This problem becomes even more difficult when the distance between the wireless radio transmitter and receiver changes during the transmission (for example, when the patient is being transported between two different procedure rooms while the data are transmitted wirelessly and are monitored in real time by physicians/nurses in a control room).
This invention further extends the EMI-filtering approach, described in the parent patent applications (Ser. Nos. 15/442,705 and 14/470,923), which uses time-domain features of EMI (in particular GMF) patterns and time-domain features of physiological waveforms to differentiate EMI patterns from physiological waveforms in the input signals.
In contrast to prior art, which requires a dedicated input channel for the GMF signal, the methods and systems of this invention are not limited to a dedicated input channel for GMF detection and identification (although the methods and systems of this invention can receive such GMF [or EMI] information using a dedicated channel such as a cable connection to an MRI scanner, a cable connection to the MRI gradient amplifiers, or a dedicated coil/antenna, if available).
Importantly, this invention enables EMI detection and identification in a plurality of signals, including various physiological signals, which may contain both physiological information and EMI-(or GMF-) generated artifacts. The signals are obtained using various types of physiological sensors, e.g., ECG electrodes, EEG electrodes, and other physiological sensors. As stated earlier, GMF detection is performed using the differences between features (e.g., 1st time derivative, 2nd time derivative, amplitude, time intervals between the waveform peaks, time intervals between the peaks of the time derivatives, time intervals between the peaks of the time derivatives and waveform peaks) of the GMF and physiological waveforms. For example, the derivatives of the GMF are usually substantially higher than those for physiological signals (e.g., the ECG R wave). Because the method and system of this invention provide GMF recognition and filtering within various physiological and non-physiological signals, which may have multiple sources (components), it can also provide GMF detection in a GMF-dedicated channel (a direct cable connection to an MRI scanner or a dedicated coil/antenna, if available).
In contrast to prior art, which usually captures GMF information directly from its source (an MRI scanner or an output from the scanner's magnetic-field gradient amplifiers), the methods and systems of this invention enable the detection of GMF interference captured by various sensors (e.g., ECG sensors) away from the GMF source. The GMF interference captured by physiological sensors and detected by the methods and systems of this invention may contain patterns of GMF interference that are different from GMF patterns generated by an MRI scanner. For example, this invention enables the detection of GMF interference in the signals captured by ECG sensors, which contain the 1st time derivative of the GMF waveforms generated by an MRI scanner.
The methods and systems of this invention, which can be implemented using analog electronics and circuitry, digital electronic elements (e.g., the firmware installed in a microcontroller, field programmable gate array [FPGA], programmable logic device [PLD], or complex programmable logic device [CPLD], computer software), or combination thereof, include two or more of the following features:
This invention provides a way to use a single system for patient monitoring during various interventional procedures (including X-ray- and MR-guided procedures), eliminating the need for multiple detachments/reattachments of various monitoring systems when the patient is moved from one room/procedure to another. In particular, the system of the present invention enables high-fidelity, wireless, multisensor monitoring in diagnostic suites (e.g., the interventional cardiology suite) and treatment units (e.g., intensive care unit), as well as during patient transportation between different procedures, units, hospitals, and clinics.
This invention is also useful for external cardiac defibrillation and pacing also require cardiovascular monitoring (e.g., ECG, blood pressure, pulse oximetry) in order to evaluate cardiac rhythm before and after defibrillation (electrical discharge or shock) or cardiac pacing, to detect cardiac arrhythmias (e.g., ventricular fibrillation, ventricular tachycardia, atrial fibrillation), or to perform a cardioversion (i.e., a synchronized shock delivered at a specific time point of the cardiac cycle, usually within the QRS complex on the ECG, which coincides with ventricular depolarization) or demand pacing, in which the patient's cardiac beats are monitored and pacing is inhibited when they are detected.
In some preferred embodiments, the method and system of this invention are incorporated into (or attached to, or housed together with) an external cardiac defibrillator/monitor (e.g., LifePak 20, Physio-Control, Redmond, Wash.), as disclosed in Shusterman U.S. Patent Application 62/490,031. In other preferred embodiments, the method and system of this invention can be connected by cable or cables to an external defibrillator and/or cardiac pacing device.
The system utilizes adaptive and versatile modular architecture with a set of modules for various filtering, conditioning, processing, and wireless transmission functions, which can be assembled in different configurations for different settings. In some preferred embodiments, the method and system of this invention are incorporated into (or attached to) an external cardiac defibrillator/monitor or cardiac pacing device. Other preferred embodiments include a wireless monitoring system that provides reliable wireless data transmission during patient table (bed) movement. To achieve reliable, real-time transmission of large volumes of data, some embodiments of the invention employ one or more wireless transmitters.
As explained above, the powerful EMI generated by the MRI systems contaminates physiological signals and necessitates data filtering. In particular, filtering is required to remove GMF interference, whose frequency spectrum often overlaps with that of the ECG signals and whose magnitude may be substantially higher than that of the ECG signals.
Because the system of the present invention is mobile and wireless, it preferably should not have any physical connection to the MRI scanner or its control equipment, which are commonly used as a source of information about MR gradients. Instead, the system of this invention utilizes the electrodes, associated cables/electronic circuitry, and the body of a monitored individual as a receiving antenna and circuitry for detecting, filtering, and analyzing features and patterns of EMI. In particular, the system of the present invention separates GMF interference from physiological signals, using a-priori information (criteria) about differences of these signals' characteristics. These include differences in time-domain features (e.g., amplitude, derivatives, area, integral and waveform patterns) and frequency-domain features (dominant frequency and frequency range). The criteria are adjusted using the measurements performed at different distances from the magnet (i.e., at different strengths of magnetic field) in the presence and/or absence of working MR gradients, as detailed in the Description of the Preferred Embodiments.
The system of present invention also reconstructs physiological signals in the presence of strong MHE, using the measurements performed at different distances from the magnet (i.e., at different strengths of magnetic field), and changes in blood flow and blood pressure, which affect the magnitude of MHE.
To summarize, the system of the present invention includes the following innovative features:
One important aspect of this invention is mounting (linking/connecting) a wireless antenna to a movable/wheeled patient table (herein, the terms patient table, bed, and procedure table are used interchangeably) to enable reliable wireless data transmission at different locations of the patient table and during its movement in the course of various procedures, as well as between different procedures and/or rooms. An important aspect of this invention is the positioning of one or more antennas connected to a wireless transmitter and one or more antennas connected to a wireless receiver (herein referred to as the first and second antenna, respectively) to provide a free (unobstructed) plane (space) for substantially continuous wireless communication between the two antennas at various positions of the patient table and during table movement.
The wireless system of this invention, which provides monitoring of the health data of an individual lying on a movable/wheeled patient table, includes:
An important aspect of this invention is adapting digital signal processing (DSP) operations based on the properties of EMI and cardiac-activity waveforms as described below.
A full understanding of the invention can be gained from the following description of the preferred embodiments when read in conjunction with the accompanying drawings in which:
The system of the present invention utilizes one or more of the following approaches implemented using DSP and/or analog electronics:
I. MR-Gradient Detector
In most pulse sequences employed in modern MR scans, MR gradients generate voltages with magnitudes and derivatives which are substantially higher than those of electrophysiological signals (e.g., ECG, EEG, EMG).
As stated earlier, the methods and systems of this invention provide GMF detection without the need for a separate, dedicated input channel providing for the GMF (or EMI) signal. While the methods and systems of this invention can receive such GMF (or EMI) information using a dedicated channel (a cable connection to the GMF source, e.g., an MRI scanner, its gradient-amplifier unit [cabinet], or a dedicated coil/antenna, if available), they can also use other signal types which do not originate from the GMF-generating source (e.g., MRI scanner) and which may include physiological signals obtained from an individual's body using various types of physiological sensors. The sensors (e.g., ECG, EMG, or EEG electrodes) may be attached (or located in close proximity) to the body of an individual (human or animal subject) or may remain unattached. For example, the GMF interference encountered in the ECG signal represents the 1st time derivative of the magnetic-field gradients generated by an MRI scanner.
The signals obtained from physiological sensors may contain both physiological information (waveforms) and GMF-generated patterns (artifacts). As stated earlier, GMF detection is performed using the differences between time-domain features (e.g., 1st time derivative, 2nd time derivative, amplitude, time intervals between the peaks, time intervals between the peaks of the time derivatives, time intervals between the peaks of the time derivatives and waveform peaks) of the GMF patterns and physiological waveforms. For example, the derivatives of the GMF are usually substantially higher than those for physiological signals (e.g., the ECG R wave).
The data-acquisition, filtering, and processing module/cascade (whose various implementations are shown in
The data-acquisition and processing module/cascade includes the following principal elements (
Various embodiments of the processing elements may include one or more of the following elements, as shown in the example implementation of the data-acquisition and processing circuitry (
The example implementation of the data-acquisition and processing circuitry shown in
EMI blanking is achieved if the following three conditions are satisfied:
If only the first condition (condition a) described above is satisfied, the example implementation of the data-acquisition and processing circuitry shown in
Various embodiments of the processing elements may include one or more of the following elements, as shown in the example implementation of the data-acquisition and processing circuitry (
The example implementation of the data-acquisition and processing circuitry shown in
EMI blanking is achieved if the following three conditions are satisfied:
If only the first condition (condition a) described above is satisfied, the example implementation of the data-acquisition and processing circuitry shown in
If the EMI's derivative (edge, slope) is smaller than the detection threshold of the EMI edge detector 1303, such EMI will not be detected by detector 1303. In this case, the EMI can be detected by the level detector 1304 and filtered (subtracted) from the signal by the differential amplifier element 1308 with the switch 1324.
In some preferred embodiments, the data-acquisition and processing cascade described above and shown in
Example systems of this invention may include various combinations of the data-acquisition, processing, filtering, conditioning, and wireless transmission modules described in the specification and shown in
Example systems of this invention may use a wireless and/or non-wireless (e.g., USB cable) connection for transferring the data to a PC without delay (which is inherent for wireless transmission at 2.4 or 5.2 GHz). In some preferred embodiments, the system utilizes the data-acquisition and processing circuitry disclosed on
The filtering and conditioning module, in particular the data-acquisition and processing cascade described above, may be implemented in a microcontroller (e.g., Texas Instruments, MSP-430), a microprocessor (e.g., Texas Instruments KEYSTONE, ARM CORTEX, C6000, Intel CORE i7 or ATOM, or an ATMEL ARM CORTEX processor), an FPGA (e.g., Xilinx SPARTAN FPGA, Xilinx VIRTEX FPGA, or Altera Cyclone FPGA), a CPLD, a system-on-chip, or a general-purpose personal computer.
The systems and methods of this invention may further include a second processing module to provide one or more additional filtering and processing operations. The second processing module may include a wireless radio receiver for receiving data from the sensor and/or processing module, which may be connected to a wireless radio transmitter (e.g., a 2.4 GHz wireless transmitter such as Wi-Fi, Bluetooth, or ZigBee radio).
II. Filtering GMF Using Parallel Filterbanks
The system of the present invention employs two or more banks of filters (filterbanks) or DSP filtering procedures, which are selected using a mechanical, electronic, or software-controlled (programmable) switch. Filterbank I allows recording of gold-standard, diagnostic-quality physiological signals, using the settings specified in the appropriate performance standards (e.g., diagnostic ECG signals using a frequency band of 0.05-250 Hz, as specified in ANSI/AAMI EC11:1991/(R)2007 “Diagnostic electrocardiographic devices”). However, Filterbank I cannot effectively filter out GMF interference, which often overlaps with the spectrum of the ECG signals. Filterbank II is designed for filtering out GMF interference (e.g., using a low-pass, 8th-order Butterworth filter with a 40-Hz 3 dB cutoff frequency) but does not provide the bandwidth required for diagnostic ECG evaluation of the cardiac waveforms (e.g., changes in the ST segment and T wave).
Block diagrams of several configurations of a medical device of this invention with different types of arrangements of the filterbanks and GMF detector are shown in
The switchable filterbanks allow clinicians to use a single monitoring system for various procedures with different levels of EMI. For example, Filterbank I can be used to obtain diagnostic ECG in environments with relatively low levels of EMI, e.g., during the course of X-ray guided cardiovascular procedures, patient transport, and bedside monitoring. Switching from Filterbank I to Filterbank II allows uninterrupted data monitoring in environments with a high level of EMI, such as MRI.
In addition, switchable filterbanks are useful for efficient filtering and reconstruction of physiological signals, as described below.
III. Filtering GMF Using Time-Domain GMF Features
Because GMF interference is several orders of magnitude greater than cardiac electrical activity, it may cause saturation of amplifiers and/or filters in monitoring systems' electronic circuitry.
The utility of frequency-domain filtering of GMF interference is limited by an overlap between the frequency ranges of physiological signals (e.g., ECG has a frequency range of 0.05-250 Hz) and GMF interference (80-1000 Hz). In addition, the amplitude and derivative of the GMF signal are several orders of magnitude greater than those for physiological signals, and with respect to the low-amplitude/derivative physiological signals, it can be approximated by Dirac delta or Heaviside step function (the integral of the delta function). The frequency power spectrum of the delta function has a constant amplitude and broad distribution (spans all frequencies). Therefore, time-domain approaches implemented in DSP and/or analog electronics are beneficial for filtering GMF signals, as shown below. They include bitwise operations combined with voltage division and/or multiplication, pattern recognition, template matching, and wavelet-based filtering tailored to characteristics and/or patterns of the GMF signals.
In one embodiment of the present invention, voltage division is applied to the “raw,” unfiltered signals as the first, pre-processing step, in order to prevent amplifier saturation (
This signal conditioning using bitwise operations includes the following operations:
IV. Filtering GMF and MHE Using Signal Reconstruction
Filtering GMF interference and reconstructing ECG waveforms (or other physiological signals) includes the following steps (and their variations):
However, in a real-life setting, the measurement errors e are relatively large, and the measured signal often contains a significant amount of noise. To minimize the magnitude of noise, the present invention utilizes the truncated singular value decomposition (SVD) of a square matrix, {tilde over (X)}T {tilde over (X)}, which is constructed from the measured signal, {tilde over (X)}, as a time-aligned series of physiological events (e.g., using the R peaks of consecutive cardiac complexes in the ECG signal), and {tilde over (X)}T denotes {tilde over (X)} transposed. The SVD is equivalent to the Principal Component Analysis and Karhunen-Loeve decomposition, which represent linear orthogonal decompositions, in which the basis vectors (eigenvectors or eigenfunctions) with the smallest weights (eigenvalues) are truncated. The truncation is based on the idea that the eigenvectors associated with the largest eigenvalues correspond to the measured signal, whereas those associated with small eigenvalues correspond to measurement noise (Shusterman U.S. Pat. Nos. 8,388,530; 7,801,591 and 7,485,095; Odille et al. Noise cancellation signal processing method and computer system for improved real-time electrocardiogram artifact correction during MRI data acquisition. IEEE Transactions on Biomedical Engineering 54[4]:630-40 [2007)],
X+({tilde over (X)}T{tilde over (X)})−1{tilde over (X)}T=(UΣVT)−1{tilde over (X)}T=(VΣ−1UT){tilde over (X)}T˜(V{tilde over (Σ)}−1UT){tilde over (X)}T
where XT is the transpose of X and {tilde over (Σ)} is the truncated SVD of the diagonal matrix Σ of singular values (eigenvalues), in which the singular values that are less than a certain threshold are set to zero, reducing the rank of the associated matrix (V{tilde over (Σ)}−1UT), which yields the following estimate of the regression coefficients:
b˜(V{tilde over (Σ)}−1UT){tilde over (X)}Ty.
The properties of this linear orthogonal transform are well established. In particular, it is known that the transform provides a least-squares solution using the smallest number of the basis vectors associated with the largest eigenvalues (Shusterman U.S. Pat. Nos. 8,388,530; 7,801,591 and 7,485,095). This procedure is similar to signal averaging, which is also used to reduce the impact of noise in the method of the present invention.
If the reconstruction accuracy needs to be further increased, the process of computing the transfer matrix X+ is treated as a minimization problem, with the goal (objective function) of minimizing the difference (and/or maximizing cross-correlation) between the two signals, using one or more methods selected from optimization algorithms. The optimization methods include simplex algorithm, iterative methods (e.g., Newton's method and quasi-Newton method, finite-difference method, and other methods of approximation theory and numerical analysis, methods that evaluate gradients using finite differences, sequential quadratic programming, approximate Hessians, gradient-descent or steepest-descent methods, ellipsoid method, simultaneous perturbation stochastic approximation, interpolation methods, and global convergence methods) and heuristic algorithms (e.g., memetic algorithm, differential evolution, differential search, dynamic relaxation, genetic algorithms, Hill climbing, Nelder-Mead algorithm, reactive search optimization).
The magnitude of MHE may change due to changes in blood pressure, arterial pressure wave, blood volume, or blood flow. To track changes in these parameters, the system of the present invention uses one or more measurements selected from the MR-based measurements of blood flow, arterial pressure waves and/or blood volume, intra-arterial blood pressure, intra-cardiac blood pressure, venous blood pressure, noninvasively measured blood pressure, arterial and/or intra-cardiac pressure waves measured by photoplethysmography, plethysmography, electrical impedance, pulse oximetry, accelerometry, acoustic waves, ultrasound, infrared, and other optical, mechanical, and electrical signals obtained from an individual's body.
If significant changes in these signals are detected, the transfer matrix X+ is further adjusted, using one or more of the following methods:
The reconstruction process described above may lead to inaccurate results if the shape of the ECG waveforms deviates from the dominant waveforms, which have been used for computing the transfer matrix X+. Because the dominant ECG waveform in most subjects originates from the sinus node (i.e., sinus beats), the transfer matrix X+ is based on the sinus beats in most subjects. This transfer matrix may not be accurate for reconstructing ectopic beats (e.g., premature atrial complexes and premature ventricular complexes). The system of the present invention allows users to display and compare both unreconstructed and reconstructed signals as they are received. It also allows viewing and comparing newly received data with templates (waveforms, patterns) obtained from multiple, averaged, or median cardiac beats/complexes (e.g., sinus beats, premature atrial complexes, premature ventricular complexes).
This invention provides a novel and efficient way to obviate the limits of the data-transmission rate (speed) of wireless communication, as well as its inherent vulnerability to transmission losses, delays, and complete interruptions, which create significant technical difficulties for the development of multichannel, wireless monitoring systems. It provides fast and reliable data transmission for multiple data channels in real time, using the following improvements:
I. Parallel Transmission of Multiple Channels and/or Groups of Channels Using Several Wireless Transmitters
The key elements of this invention include:
Data received by different modules can be synchronized by time markers (stamps), which include short, discrete pulses or continuous waveforms (e.g., sinusoidal waves with a constant frequency). The time markers can be generated by one module and transmitted to other modules; they can be also generated by a data-synchronization module or a motherboard and transmitted to all modules. The time markers are recorded by each module into a separate data-synchronization channel and transmitted wirelessly along with other data channels to the data-receiving station. The software on the receiving station (e.g., desktop computer, laptop, smart phone) utilizes the time markers to synchronize the data received from different modules. The synchronization is achieved by time-aligning the time markers, as well as simultaneously acquired data channels received from all modules.
II. Wireless Transmission Using Multiple Transmitters that Operate in Different Frequencies (Frequency Ranges) to Prevent Transmission Loss/Failure
A medical device of this invention improves the reliability of wireless transmission (which may become unreliable in the presence of EMI, electromagnetic shields, or changing distance and position of the transmitter relative to a receiver). Distribution of wireless transmission into several independent data streams can provide backup for potential failures in some of the wireless transmission links.
Block diagrams of several configurations of the data-acquisition and filtering parts of a medical device of this invention are shown in
In
When the level of GMF is very high, a medical device of this invention uses an MR-gradient detector 60, which is connected to a processing filterbank module 40, as shown in
Configuration of a wireless communication unit of a medical device of this invention, as well as data-synchronization unit/interface, are shown in
The wireless modules serve two purposes:
In this configuration, each module acquires and transmits data via its associated wireless transmitter, producing parallel data streams, which are aggregated, synchronized, processed, and displayed at the receiving station (not shown). The modules are synchronized using a periodic impulse and/or frequency signal (with known frequency characteristics, e.g., a 1 kHz sine wave), which serve as time markers. These time markers are generated by Module #1 or a separate data-synchronization module/interface 30 and recorded to the reference-data channel of all modules, along with simultaneously acquired data channels. Because the time markers are generated and recorded by each module simultaneously with other data channels, the receiving station synchronizes the data by time aligning the corresponding time markers (as well as simultaneously acquired data channels) in all modules.
In another configuration of a medical device of this invention, wireless transmission includes intelligent, “on-demand” re-routing of data from failed wireless links (transmitters) to working ones. Examples of such wireless transmitters include: (i) transmitters of the same type (e.g., two Bluetooth transmitters), (ii) transmitters of different types (e.g., Bluetooth and Wi-Fi), and (iii) transmitters of the same type but with different transmission frequencies (e.g., Wi-Fi operating on 2.4 and 5.2 GHz).
Wireless transmitters of the same type often share the same transmission frequency range. For example, Bluetooth transmitters use ˜2.4 GHz frequency range with adaptive frequency hopping, which may create interference between several Bluetooth radios transmitting data at the same time. To obviate this problem, the Bluetooth transmission protocols in one configuration of a medical device of this invention are adapted to the presence of other Bluetooth transmitters by dividing the transmission spectrum, thus avoiding interference between them.
Because the first antenna 5 stays with the patient table as the table (and the patient) is being moved during a procedure or between different procedure rooms, it provides uninterrupted wireless communication during patient (and patient-table) movement. The second antenna 7 is mounted on the ceiling or on the wall; it extends at least six feet above the floor to provide unimpeded communication with the first antenna 5 during table movement as well as during the movement of medical personnel and equipment around the table (bed). Thus, in this embodiment, wireless communication between the two antennas is carried out in the space (plane) at least six feet above the floor that is not affected by patient-table, personnel, or equipment movement. The second antenna 7 is connected to the receiving and processing unit/module 8, which is located in the same room (mounted on the ceiling or on the wall) or in another (e.g., adjacent) room.
In one embodiment, the transmitting antenna extends to at least six feet above the floor to provide substantially unobstructed communication with one or more receiving antennas, which are also positioned at least six feet above the floor.
In one embodiment, the transmitting antenna is located below patient level to provide substantially unobstructed communication with one or more receiving antennas located on the floor surface (below the patient). In one embodiment, the frame of the patient table (bed) serves as a transmitting antenna.
In one embodiment, the transmitting antenna is fed through (mounted inside) a hollow pole, which can be also used for hanging IV fluid bags. In a preferred embodiment, the pole is mounted (connected) to the patient table. The antenna mount is attached to the patient table using, for example, a c-clamp, and stays with the patient table as the patient is moved during different procedures as well as between different procedure rooms.
An important aspect of this invention is adaptive filtering and signal conditioning implemented in a DSP module/unit. The DSP operations are adapted to the properties of EMI and recorded data (physiological signals), using:
The system of this invention provides means (tools, mechanisms) for the channel selection and control (adaptation) of the DSP operations described above. These control means include one or more of the following tools:
An important aspect of this invention is the selection of the channel for the detection of EMI spikes/peaks/artifacts (herein referred to as the “base-EMI channel”). Similar to the cardiac-activity-waveform tracking described below, the invention relies on the fact that the time of EMI peaks is the same in all channels. Therefore, the time points of occurrence of EMI peaks are determined in the base-EMI channel first. Subsequently, the same time points are used for tracking (and filtering) EMI in other channels.
The base-EMI channel is selected either by user (user-guided selection) or by the system (unguided selection) based on automatically determined EMI signal characteristics, such as the EMI-peak magnitude and/or signal-to-noise ratio (SNR).
When the times of occurrence of EMI peaks have been determined in the base-EMI channel, the EMI filtering is performed in other channels (physiological signals), using:
The EMI-detection and -filtering parameters, including the magnitude and derivative thresholds for detecting EMI peaks, duration of the EMI-filtering window, and the pivot window, are selected either by a user (user-guided selection) or by the system (unguided selection) based on the EMI signal properties, such as the magnitude and duration of EMI peaks and the time interval between them.
The filtering and conditioning module identifies and tracks various forms of cardiovascular activity (e.g., ECG activity and its P, QRS, and T waves; ABP waveforms; and pulse-oximetry waveforms). The DSP module also identifies and tracks EMI, e.g., GMF-generated spikes (peaks), whose frequency spectrum may overlap with the spectrum of QRS complexes. This overlap makes discrimination between the ECG QRS complexes (or other waveforms of cardiovascular activity) and GMF-generated EMI spikes technically challenging.
The filtering and conditioning module resolves this technical challenge by enabling selection of the channel (herein referred to as the “base channel”) that is used for detection of cardiac-activity waveforms (e.g., ECG QRS complexes) and calculation of associated physiological parameters (e.g., heart rate or beat-to-beat intervals, duration of the QRS complexes and/or QT intervals). The base channel is selected either by a user (user-guided selection) or by the system (unguided selection) based on automatically determined cardiac-activity signal (waveform) characteristics, such as the magnitude of ECG R waves and/or their SNR (where noise includes ambient noise and GMF-generated EMI).
The invention relies on the fact that the time of a specific type of cardiac activity (e.g., ECG activity and its QRS complex) is the same in all channels (i.e., in all ECG leads). Therefore, it is possible to select a base channel in which cardiac activity (e.g., QRS complexes of high magnitude and high SNR) are readily identifiable and EMI is relatively small. Thereafter, this base channel is used for detection and tracking of cardiac activity (e.g., QRS complexes) and calculation of heart rate and other physiological parameters (beat-to-beat intervals, ST-segment amplitude, QT intervals, QRS duration, and T-wave amplitude). Once the time points of occurrence of the ECG QRS complexes have been determined in the base channel, the same time points are used for detecting QRS complexes in other channels. Some other examples of physiological signals that can also be detected and tracked using the base channel include ECG P waves and T waves, ABP waveforms, pulse-oximetry waveforms, and other cardiovascular parameters.
The cardiac-waveform (e.g., ECG QRS complexes) detection parameters, including the magnitude and derivative thresholds, the QRS duration, and the time interval between adjacent QRS complexes, are selected either by a user (user-guided selection) or by the system (unguided selection) based on the properties of the cardiac waveforms, such as the magnitude and duration of ECG QRS complexes or other ECG waves, as well as their SNR. Averaging and other forms of low-pass filtering are used to improve the SNR. Parameter selection may also include the properties of cardiac activity (e.g., the magnitude and duration of ECG QRS complexes or other ECG waves, the time interval between adjacent QRS complexes, and their SNR).
The filtering and conditioning module is implemented in a microcontroller (e.g., Texas Instruments, MSP-430), a microprocessor (e.g., Texas Instruments KEYSTONE, ARM CORTEX, C6000, Intel CORE i7 or ATOM, or an ATMEL ARM CORTEX processor), an FPGA (e.g., Xilinx SPARTAN FPGA, Xilinx VIRTEX FPGA, or Altera Cyclone FPGA), a CPLD, a system-on-chip, or a general-purpose personal computer.
Interventional MRI (I-MRI) allows physicians to perform minimally invasive and catheter-based diagnostic procedures, providing high-quality images of internal organs, without exposure to harmful ionizing radiation. I-MRI requires telemetry monitoring of patients' vital signs; however, existing telemetry monitors have electromagnetic compatibility issues: MRI equipment is affected by EMI from telemetry systems, and telemetry data are degraded by the EMI generated by the MR scanner. Commercial applications of the technology are expected to be in all areas of I-MRI. Because I-MRI enables physicians to perform minimally invasive procedures, eliminating the need for more invasive and traumatic procedures, its role in diagnostic evaluation is expected to grow rapidly.
As the field and applications of I-MRI continue to grow and diversify, the need for wireless-telemetry monitoring of various physiological signals (multi-channel ECG, blood pressure, and pulse oximetry) is expected to follow. Thus it is important to develop a platform technology that is not limited to a small number of signals/channels, but has a sufficient number of channels and functions to be utilized for various future applications.
One particularly important emerging area of I-MRI is CMR, which requires high-fidelity, real-time monitoring of multi-channel ECG for timely detection of life-threatening arrhythmias (which can be induced by cardiac catheterization) or the first signs of ischemic changes in the ST-segment. The latter is essential for the monitoring of patients with known or suspected coronary artery disease undergoing an exercise stress CMR test.
However, currently available ECG telemetry systems are limited to a few channels of non-diagnostic-quality ECG, which cannot provide accurate tracking of the ST segment's amplitude and thus do not allow accurate and timely detection of potentially life-threatening ischemic events. Moreover, several telemetry units would be required for wireless monitoring of ECG, oxygen saturation, and ABP, creating logistical difficulties for the medical personnel performing I-MRI procedures.
Example systems of this invention may use wireless and/or non-wireless (e.g., USB cable) connection for transferring the data to a PC without delay (which is inherent for the wireless transmission at 2.4 or 5.2 GHz). In some preferred embodiments, the system utilizes the data acquisition and processing circuitry disclosed on
In this hypothetical example, an interventional CMR procedure is performed in a human subject, using a medical device of this invention. First, 10 ECG cables (for acquiring 12-lead ECG), two cables for monitoring blood pressure using fluid-filled pressure cables, a cable for monitoring blood pressure noninvasively, and a fiber-optic cable for monitoring pulse wave (pulse oximetry) are attached to the subject. The first set of signals may be acquired outside the magnet bore providing an MHE-free reference data. The second set of signals may be acquired after the patient is moved inside the magnet bore but before scanning begins. This set of signals contains MHE but not GMF interference. The third set of signals may be acquired during the MR scan and contains both MHE and GMF interference. Applying filtering and reconstructive procedures described in the Summary of Invention, diagnostic physiological signals may be reconstructed from those obtained during the MR scan.
Because the number of channels and their sampling rate are relatively high, the data are transmitted in two parallel data streams using two wireless transmitters. The first transmitter transmits 8 ECG channels, whereas the second transmits blood-pressure and pulse-oximetry channels. The data are time-stamped using time markers (periodic impulses) that are recorded using a dedicated reference channel in each data stream. These time markers are used by the receiving station to synchronize the two data streams by time-aligning the corresponding time markers.
Interventional CMR procedures often require X-ray imaging as well. For this purpose, patient table is quickly moved to an adjacent X-ray imaging room. Because a medical device of this invention is wireless, it does not restrict movement of the patient table and provides uninterrupted monitoring during patient transportation from the MR room to the X-ray room. To provide diagnostic-quality monitoring during an X-ray (fluoroscopy)-guided procedure (which does not have a high-level GMF), Filterbank II can be switched to Filterbank I.
This hypothetical example describes the application of a medical device of this invention for an MR-guided cardiac electrophysiology study. The monitoring procedure is similar to that described in example 1. However, the system configuration required for this time-critical setting is different.
Example systems of this invention may use a wireless and/or non-wireless (e.g., USB cable) connection for transferring the data to a PC without delay (which is inherent for wireless transmission at 2.4 or 5.2 GHz). In some preferred embodiments, the system utilizes the data-acquisition and processing circuitry disclosed on
In some preferred embodiments, the system of this invention may utilize two parallel data streams passed through both Filterbanks I and II to allow clinicians to monitor interchangeably or concurrently signals passed through both filterbanks.
Example systems of this invention may utilize a wireless transmission architecture, in which all data channels are transmitted at two different frequencies (2.4 and 5.2 GHz), using two wireless transmitters, to ensure uninterrupted transmission of all data channels in this time-critical setting. This redundant transmission ensures that the receiving station receives all the data channels if one transmission frequency becomes unavailable or experiences a transmission delay.
This hypothetical example describes the application of a medical device of this invention for external cardiac defibrillation and transcutaneous pacing during MRI procedures. External defibrillation and electrical pacing are frequently required in the course of MR-guided electrophysiology procedures, when a cardiac arrhythmia is induced or occurs spontaneously and requires termination. In order to provide synchronized cardioversion (i.e., shock delivery synchronized with a specific part of the cardiac cycle, usually with ventricular depolarization, using the QRS complex or its R wave on the ECG as a time marker) and/or “demand” pacing (i.e., delivery of electrical pacing stimuli with simultaneous monitoring of the patient's intrinsic cardiac beats and inhibition/cessation of pacing in the presence of the patient's intrinsic cardiac activity), external defibrillators and/or pacing systems require continuous physiological monitoring in the presence of EMI generated by the Mill scanners.
Example systems of this inventions may include an accessory for an external defibrillator, which may be attached to the defibrillator (e.g., an accessory disclosed in Shusterman U.S. Patent Application 62/490,031). To provide EMI-free monitoring of physiological signals, the accessory may include the data-acquisition and processing circuitry disclosed on
In this hypothetic example, a ventricular tachyarrhythmia spontaneously occurs during an MR-guided electrophysiology study. External defibrillation is applied using a system of this invention (with an EMI-minimizing accessory disclosed in Shusterman U.S. Patent Application 62/490,031). The accessory provides uninterrupted monitoring of the physiological signals in the presence of EMI, before and after the defibrillation. By monitoring physiological signals (e.g., ECG, blood pressure, pulse oximetry) continuously, clinicians are able to track changes in cardiac waveforms and determine the type of cardiac rhythm. This is particularly important for determining the success or failure of each defibrillation attempt without delay.
This hypothetical example describes the application of a medical device of this invention for high-resolution brain imaging requiring data recording from up to 100 channels simultaneously, at a high sampling frequency. The monitoring and setup procedures are similar to those described in examples 1 and 2. However, because the number of monitoring channels is bigger, the system configuration is expanded to include ten data-acquisition modules with associated wireless transmitters, which are time-synchronized as described above.
Whereas particular aspects of the method of the present invention and particular embodiments of the invention have been described for purposes of illustration, it will be appreciated by those skilled in the art that numerous variations of the details may be made without departing from the invention as described in the appended claims.
This application is a continuation-in-part of pending U.S. patent application Ser. No. 15/442,705 filed on Feb. 27, 2017, which is a continuation-in-part of U.S. patent application Ser. No. 14/470,923 filed on Aug. 27, 2014 (now U.S. Pat. No. 9,610,016), which are incorporated herein by reference.
This invention was made with government support under contract HHSN268201400021C awarded by the National Institutes of Health. The government has certain rights in the invention.
| Number | Name | Date | Kind |
|---|---|---|---|
| 5187657 | Forbes | Feb 1993 | A |
| 5730146 | Itil | Mar 1998 | A |
| 6221011 | Bardy | Apr 2001 | B1 |
| 6753783 | Friedman | Jun 2004 | B2 |
| 7508307 | Albert | Mar 2009 | B2 |
| 8137270 | Keenan | Mar 2012 | B2 |
| 8388530 | Shusterman | Mar 2013 | B2 |
| 8437843 | Kayyali | May 2013 | B1 |
| 8781563 | Foo | Jul 2014 | B2 |
| 9183351 | Shusterman | Nov 2015 | B2 |
| 10055549 | Chung | Aug 2018 | B2 |
| 20050165323 | Montgomery | Jul 2005 | A1 |
| 20060183980 | Yang | Aug 2006 | A1 |
| 20070010721 | Chen | Jan 2007 | A1 |
| 20070288265 | Quinian | Dec 2007 | A1 |
| 20110004110 | Shusterman | Jan 2011 | A1 |
| 20130172691 | Tran | Jul 2013 | A1 |
| 20130231947 | Shusterman | Sep 2013 | A1 |
| 20140081100 | Muhsin | Mar 2014 | A1 |
| 20140213872 | Rahman | Jul 2014 | A1 |
| 20140266776 | Miller | Sep 2014 | A1 |
| 20150106020 | Chung | Apr 2015 | A1 |
| Number | Date | Country | |
|---|---|---|---|
| 20190159733 A1 | May 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62622996 | Jan 2018 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15442705 | Feb 2017 | US |
| Child | 16260098 | US | |
| Parent | 14470923 | Aug 2014 | US |
| Child | 15442705 | US |
